Silverman Stuart L
Cedars-Sinai Medical Center, David Geffen School of Medicine UCLA, OMC Clinical Research Center, Beverly Hills, Calif. 90211 , USA.
Am J Med. 2009 Feb;122(2):114-20. doi: 10.1016/j.amjmed.2008.09.030.
Randomized controlled trials are considered the gold standard in the hierarchy of research designs for evaluating the efficacy and safety of a treatment intervention. However, their results can have limited applicability to patients in clinical settings. Observational studies using large health care databases can complement findings from randomized controlled trials by assessing treatment effectiveness in patients encountered in day-to-day clinical practice. Results from these designs can expand upon outcomes of randomized controlled trials because of the use of larger and more diverse patient populations with common comorbidities and longer follow-up periods. Furthermore, well-designed observational studies can identify clinically important differences among therapeutic options and provide data on long-term drug effectiveness and safety.
随机对照试验被认为是评估治疗干预效果和安全性的研究设计层级中的金标准。然而,其结果在临床环境中对患者的适用性可能有限。利用大型医疗保健数据库进行的观察性研究可以通过评估日常临床实践中遇到的患者的治疗效果,来补充随机对照试验的结果。由于使用了更大、更多样化且患有常见合并症的患者群体以及更长的随访期,这些设计的结果可以扩展随机对照试验的结果。此外,精心设计的观察性研究可以识别治疗方案之间临床上的重要差异,并提供关于长期药物有效性和安全性的数据。